LYMPH-NODE METASTASES IN CARCINOMA OF THE CERVIX UTERI - RESPONSE TO NEOADJUVANT CHEMOTHERAPY AND ITS IMPACT ON SURVIVAL

被引:59
作者
GIAROLI, A
SANANES, C
SARDI, JE
MAYA, AG
BASTARDAS, ML
SNAIDAS, L
RUEDA, NG
VIGHI, S
DIPAOLA, GR
机构
[1] Oncology Department, Buenos Aires University, CP 1120 Buenos Aires
关键词
D O I
10.1016/0090-8258(90)90395-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
One hundred and sixty-nine patients with squamous cancer of the cervix uteri treated with three courses of neoadjuvant chemotherapy with the modified VBP scheme are presented. All were subjected to a Wertheim-Meigs operation with paraaortic lymph-adenectomy. The incidence of lymph node metastases is analyzed according to clinical stage, tumor volume, residual tumor in the surgical specimen, and clinical response to neoadjuvant chemotherapy. A significant decrease in the incidence of lymph node involvement was observed in good responders. Survival rates, after 2 years of follow-up, improved in those cases with small residual tumor, negative parametria, and negative nodes. © 1990.
引用
收藏
页码:34 / 39
页数:6
相关论文
共 22 条
[1]  
BUNKE T, 1987, GYNECOL ONCOL, V26, P153
[2]   MAGNETIC-RESONANCE IMAGING IN CERVICAL-CANCER - A BASIS FOR OBJECTIVE CLASSIFICATION [J].
BURGHARDT, E ;
HOFMANN, HMW ;
EBNER, F ;
HAAS, J ;
TAMUSSINO, K ;
JUSTICH, E .
GYNECOLOGIC ONCOLOGY, 1989, 33 (01) :61-67
[3]   ANALYSIS OF FACTORS CONTRIBUTING TO TREATMENT FAILURES IN STAGE-IB AND STAGE-II-A CARCINOMA OF THE CERVIX [J].
CHUNG, CK ;
NAHHAS, WA ;
STRYKER, JA ;
CURRY, SL ;
ABT, AB ;
MORTEL, R .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1980, 138 (05) :550-556
[4]  
CHUNG CK, 1981, GYNECOL ONCOL, V12, P348, DOI 10.1016/0090-8258(81)90135-9
[5]   THE INTEGRATION OF CHEMOTHERAPY INTO THE MANAGEMENT OF LOCALLY ADVANCED CERVICAL-CANCER - A PILOT-STUDY [J].
FRIEDLANDER, ML ;
ATKINSON, K ;
COPPLESON, JVM ;
ELLIOT, P ;
GREEN, D ;
HOUGHTON, R ;
SOLOMON, HJ ;
RUSSELL, P ;
TATTERSALL, MHN .
GYNECOLOGIC ONCOLOGY, 1984, 19 (01) :1-7
[6]   LYMPH-NODE METASTASES FROM CARCINOMA OF THE CERVIX, STAGES IB AND IIA - IMPLICATIONS FOR PROGNOSIS AND TREATMENT [J].
FULLER, AF ;
ELLIOTT, N ;
KOSLOFF, C ;
LEWIS, JL .
GYNECOLOGIC ONCOLOGY, 1982, 13 (02) :165-174
[7]  
KIM D, 1988, GYNECOL ONCOL, V29
[8]   2-YEAR SURVIVAL - PREOPERATIVE ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF CERVICAL-CANCER STAGE-IB AND STAGE-II WITH BULKY TUMOR [J].
KIM, DS ;
MOON, H ;
KIM, KT ;
HWANG, YY ;
CHO, SH ;
KIM, SR .
GYNECOLOGIC ONCOLOGY, 1989, 33 (02) :225-230
[9]   RESULTS AND COMPLICATIONS OF OPERATIVE STAGING IN CERVICAL-CANCER - EXPERIENCE OF THE GYNECOLOGIC ONCOLOGY GROUP [J].
LAGASSE, LD ;
CREASMAN, WT ;
SHINGLETON, HM ;
FORD, JH ;
BLESSING, JA .
GYNECOLOGIC ONCOLOGY, 1980, 9 (01) :90-98
[10]  
LANZA A, 1987, PERSPECT GYNECOL OBS, V4, P15